Literature DB >> 12376610

Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation.

Esther Pallisa1, Pilar Sanz, Antonio Roman, Joaquim Majó, Jordi Andreu, José Cáceres.   

Abstract

Lymphangioleiomyomatosis (LAM) is a rare disease characterized by pulmonary cysts at computed tomography (CT) and proliferation of abnormal smooth muscle cells at lung biopsy. Almost all patients are female, and all have pulmonary cysts at high-resolution CT. Although the presence of cysts may be suggested at conventional CT or chest radiography, high-resolution CT is superior for cyst detection and is essential for diagnosis. The cysts are typically round; in most cases, the cyst wall is barely seen at thin-section CT. They are typically diffusely distributed throughout the central and peripheral lung parenchyma. The lung bases are affected in all patients. Some patients also have increased lung attenuation or a reticular pattern. Expiratory CT shows no air trapping between the cysts, and most of the cysts decrease in size. Pneumothorax, pleural effusion, and chylothorax are complications of LAM. Certain abdominal findings may provide additional corroborative evidence of the diagnosis. Renal angiomyolipomas, the most frequent abdominal lesions, usually manifest as asymptomatic, small, bilateral tumors of fat attenuation in the renal cortex. Lymphangiomas are cystic retroperitoneal masses that occur in up to 20% of patients. Other CT findings are hypo- or hyperattenuating lymph nodes, a dilated thoracic duct, and ascites. Copyright RSNA, 2002

Entities:  

Mesh:

Year:  2002        PMID: 12376610     DOI: 10.1148/radiographics.22.suppl_1.g02oc13s185

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  23 in total

1.  Pulmonary lymphangioleiomyomatosis associated with retroperitoneal lymphangioleiomyomas.

Authors:  Anastasia Oikonomou; Argyris Tzouvelekis; Petros Zezos; Demostehenes Bouros; Panos Prassopoulos
Journal:  BMJ Case Rep       Date:  2012-01-18

2.  Acute abdominal pain and shortness of breath in a female patient.

Authors:  A M Veitch; M J Hughes
Journal:  Br J Radiol       Date:  2012-04       Impact factor: 3.039

3.  Biomedical image representation approach using visualness and spatial information in a concept feature space for interactive region-of-interest-based retrieval.

Authors:  Md Mahmudur Rahman; Sameer K Antani; Dina Demner-Fushman; George R Thoma
Journal:  J Med Imaging (Bellingham)       Date:  2015-12-30

Review 4.  Imaging features of lymphangioleiomyomatosis: diagnostic pitfalls.

Authors:  Nilo A Avila; Andrew J Dwyer; Joel Moss
Journal:  AJR Am J Roentgenol       Date:  2011-04       Impact factor: 3.959

5.  Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis.

Authors:  Soichiro Yoshida; Tetsuo Hayashi; Nobuyuki Ishii; Atsushi Yoshinaga; Rena Ohno; Toshiya Terao; Toru Watanabe; Takumi Yamada; Hisato Osada
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

6.  Atypical presentation of lymphangioleiomyomatosis as jugular vein thrombosis.

Authors:  Nisar A Wani; T Kosar; T Gojwari
Journal:  Br J Radiol       Date:  2010-04       Impact factor: 3.039

7.  Primary retroperitoneal perivascular epithelioid cell neoplasm: A case report.

Authors:  Wenjie Liang; Chang Xu; Feng Chen
Journal:  Oncol Lett       Date:  2015-05-14       Impact factor: 2.967

Review 8.  A practical approach to high-resolution CT of diffuse lung disease.

Authors:  Mizuki Nishino; Harumi Itoh; Hiroto Hatabu
Journal:  Eur J Radiol       Date:  2013-02-11       Impact factor: 3.528

9.  [Newly developed dyspnea in a young adult female patient with known bilateral renal angiomyolipoma].

Authors:  A P W Jöres; T Klink
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

10.  Lymphangioleiomyomatosis: solitary abdominal manifestation (2009: 9b).

Authors:  Anne-Kristin Possekel; Detlef Katenkamp; Hans-Jürgen Brambs; Sandra Pauls
Journal:  Eur Radiol       Date:  2009-11-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.